Subclinical Atherogenesis in Patients With Mild Psoriasis: A Role for IL-6?

Revista da Associacao Medica Brasileira - Brazil
doi 10.1590/1806-9282.63.09.747
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

The Role of IL-4 in Psoriasis

Expert Review of Clinical Immunology
AllergyImmunology
2017English

Psoriasis and the MAITing Game: A Role for IL-17A+ Invariant TCR CD8+ T Cells in Psoriasis?

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

439 the Role of IL-37 in Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Pro-Atherogenic Mediators and Subclinical Atherogenesis Are Related to Epicardial Adipose Tissue Thickness in Patients With Cardiovascular Risk

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

Meta-Analysis of IL-6 -174g/C Polymorphism and Psoriasis Risk

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Blood Thrombopoietin, IL-6 and IL-11 Levels in Patients With Agnogenic Myeloid Metaplasia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Transcriptome Profiling Unveils the Role of Cholesterol in IL-17A Signaling in Psoriasis

Scientific Reports
Multidisciplinary
2016English

Regulation of IL-22BP in Psoriasis

Scientific Reports
Multidisciplinary
2018English

IL-6 Mediated JAK/STAT3 Signaling Pathway in Cancer Patients With Cachexia

Bratislava Medical Journal
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy